{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:15:02Z","timestamp":1773872102491,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jiph.2025.102841","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T19:08:44Z","timestamp":1748027324000},"page":"102841","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Assessment of clinical effectiveness and safety of ceftazidime-avibactam in \u2010treating multi-drug-resistant infections \u2013 A retrospective analysis at a tertiary care hospital in Saudi Arabia"],"prefix":"10.1016","volume":"18","author":[{"given":"Eman Merghani","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1156-2511","authenticated-orcid":false,"given":"Hanan A.","family":"Bakri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otilia J.F.","family":"Banji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5611-4782","authenticated-orcid":false,"given":"Amani","family":"Khardali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7207-7555","authenticated-orcid":false,"given":"Moaddey","family":"Alfarhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0793-5445","authenticated-orcid":false,"given":"Hilal A.","family":"Thaibah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalin A.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Eltaib","family":"Elmobark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1557-6566","authenticated-orcid":false,"given":"Anugeetha Thacheril","family":"Mohanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mousa Mohammed Hassan","family":"Tawhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zamzam O.","family":"Mashraqi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Hassan","family":"Suhaqi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majed Abdu Soliman","family":"Akam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafat Fahad Mohammed","family":"Hawbani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jiph.2025.102841_bib1","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s40265-018-0902-x","article-title":"Ceftazidime-Avibactam: a review in the treatment of serious Gram-negative bacterial infections","volume":"78","author":"Shirley","year":"2018","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.jiph.2025.102841_bib2","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.mib.2011.07.026","article-title":"Diazabicyclooctanes (DBOs): a potent new class of non-\u03b2-lactam \u03b2-lactamase inhibitors","volume":"14","author":"Coleman","year":"2011","journal-title":"Curr Opin Microbiol"},{"issue":"9","key":"10.1016\/j.jiph.2025.102841_bib3","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.3390\/microorganisms11092158","article-title":"In vitro susceptibility to ceftazidime-avibactam and comparator antimicrobial agents of carbapenem-resistant Enterobacterales isolates","volume":"11","author":"Lim","year":"2023","journal-title":"Microorganisms"},{"issue":"3","key":"10.1016\/j.jiph.2025.102841_bib4","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.clinthera.2016.01.018","article-title":"Ceftazidime-Avibactam: a novel cephalosporin\/\u03b2-lactamase inhibitor combination for the treatment of resistant Gram-negative organisms","volume":"38","author":"Sharma","year":"2016","journal-title":"Clin Ther"},{"issue":"8","key":"10.1016\/j.jiph.2025.102841_bib5","first-page":"479","article-title":"Ceftazidime-Avibactam (Avycaz): For the treatment of complicated intra-abdominal and urinary tract infections","volume":"41","author":"Mosley","year":"2016","journal-title":"P T"},{"issue":"3","key":"10.1016\/j.jiph.2025.102841_bib6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1473-3099(17)30747-8","article-title":"Ceftazidime\u2013avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomized, double-blind, phase 3 non-inferiority trial","volume":"18","author":"Torres","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiph.2025.102841_bib7","unstructured":"O'Neill J. Tackling drug-resistant infections globally: Final report and recommendations. The review on antimicrobial resistance. 2016. Available from: \u3008https:\/\/apo.org.au\/node\/63983\u3009. Accessed on: 25\/9\/2024."},{"key":"10.1016\/j.jiph.2025.102841_bib8","unstructured":"World Health Organization. Antimicrobial resistance, 2023 [Online]. Available from: \u3008https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance\u3009. Accessed on: 18 Sep 2024."},{"key":"10.1016\/j.jiph.2025.102841_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/jac\/dki166","article-title":"Emergence of Enterobacteriaceae producing extended-spectrum \u03b2-lactamases (ESBLs) in the community","volume":"56","author":"Pitout","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiph.2025.102841_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1060050","article-title":"Epidemiology of extended-spectrum \u03b2-lactamases in Enterobacterales in Taiwan for over two decades","volume":"13","author":"Chao","year":"2023","journal-title":"Front Microbiol"},{"issue":"4","key":"10.1016\/j.jiph.2025.102841_bib11","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1128\/CMR.05035-11","article-title":"Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions","volume":"25","author":"Tzouvelekis","year":"2012","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"10.1016\/j.jiph.2025.102841_bib12","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1021\/cb500703p","article-title":"Structural insight into potent broad-spectrum inhibition with reversible recyclization of Avibactam by beta-lactamases","volume":"10","author":"Lahiri","year":"2015","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.jiph.2025.102841_bib13","unstructured":"Centers for Disease Control and Prevention, About Carbapenem-resistant Enterobacterales. Available from: \u3008https:\/\/www.cdc.gov\/cre\/about\/index.html\u3009. Accessed: 28 Sep 2024."},{"issue":"10","key":"10.1016\/j.jiph.2025.102841_bib14","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3390\/pathogens10101310","article-title":"Bacterial antibiotic resistance: The most critical pathogens","volume":"10","author":"Mancuso","year":"2021","journal-title":"Pathogens"},{"issue":"2","key":"10.1016\/j.jiph.2025.102841_bib15","first-page":"114","article-title":"Antimicrobial resistance induced by genetic changes","volume":"2","author":"Coculescu","year":"2009","journal-title":"J Med Life"},{"issue":"6","key":"10.1016\/j.jiph.2025.102841_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01517-22","article-title":"Subinhibitory concentrations of antibiotics alter the response of Klebsiella pneumoniae to components of innate host defense","volume":"10","author":"Opoku-Temeng","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jiph.2025.102841_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/cid\/cir273","article-title":"Country-to-country transfer of patients and the risk of multi-resistant bacterial infection","volume":"53","author":"Rogers","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2025.102841_bib18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/CMR.00096-12","article-title":"Lactamase production in key Gram-negative pathogen isolates from the Arabian Peninsula","volume":"26","author":"Zowawi","year":"2013","journal-title":"Clin Microbiol Rev"},{"issue":"Pt 1","key":"10.1016\/j.jiph.2025.102841_bib19","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.envint.2018.06.030","article-title":"Antimicrobial resistance in the Gulf Cooperation Council region: A proposed framework to assess threats, impacts, and mitigation measures associated with AMR in the marine and aquatic environment","volume":"121","author":"Le Quesne","year":"2018","journal-title":"Environ Int"},{"key":"10.1016\/j.jiph.2025.102841_bib20","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/cid\/ciw636","article-title":"Clinical outcomes, drug toxicity, and emergence of ceftazidime-avibactam resistance among patients treated for carbapenem-resistant Enterobacteriaceae infections","volume":"63","author":"Shields","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jiph.2025.102841_bib21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/cid\/cix783","article-title":"Colistin versus Ceftazidime-Avibactam in the treatment of infections due to carbapenem-resistant Enterobacteriaceae","volume":"66","author":"Duin","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2025.102841_bib22","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s40121-023-00762-9","article-title":"The use and effectiveness of ceftazidime\u2013avibactam in real-world clinical practice: EZTEAM Study","volume":"12","author":"Soriano","year":"2023","journal-title":"Infect Dis Ther"},{"issue":"6","key":"10.1016\/j.jiph.2025.102841_bib23","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jiph.2018.04.013","article-title":"Experience with ceftazidime\u2013avibactam treatment in a tertiary care center in Saudi Arabia","volume":"11","author":"Algwizani","year":"2018","journal-title":"J Infect Public Health"},{"issue":"1","key":"10.1016\/j.jiph.2025.102841_bib24","first-page":"S27","article-title":"Infections in patients with diabetes mellitus: A review of pathogenesis","volume":"16","author":"Casqueiro","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jiph.2025.102841_bib25","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1186\/s12879-022-07507-y","article-title":"Molecular epidemiology and outcome of carbapenem-resistant Enterobacterales in Saudi Arabia","volume":"22","author":"Alraddadi","year":"2022","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.jiph.2025.102841_bib26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.15537\/smj.2018.1.21094","article-title":"The emergence of carbapenem-resistant Klebsiella pneumoniae isolates producing OXA-48 and NDM in the Southern (Asir) province, Saudi Arabia","volume":"39","author":"Al-Zahrani","year":"2018","journal-title":"Saudi Med J"},{"issue":"3","key":"10.1016\/j.jiph.2025.102841_bib27","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1089\/mdr.2014.0121","article-title":"Molecular characterization of carbapenemase production among gram-negative bacteria in Saudi Arabia","volume":"21","author":"Memish","year":"2015","journal-title":"Micro Drug Resist"},{"issue":"11","key":"10.1016\/j.jiph.2025.102841_bib28","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1093\/cid\/ciw133","article-title":"Efficacy and safety of ceftazidime-avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infection: Results from a randomized, controlled, double-blind, phase 3 program","volume":"62","author":"Mazuski","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jiph.2025.102841_bib29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3949\/ccjm.80a.12182","article-title":"Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients","volume":"80","author":"Perez","year":"2013","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.jiph.2025.102841_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1198926","article-title":"Clinical efficacy and drug resistance of ceftazidime-avibactam in the treatment of carbapenem-resistant gram-negative bacilli infection","volume":"14","author":"Xiao","year":"2023","journal-title":"Front Microbiol"},{"issue":"6","key":"10.1016\/j.jiph.2025.102841_bib31","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.cmi.2024.11.006","article-title":"Stephani S. Aztreonam and avibactam combination therapy for metallo-\u03b2-lactamase-producing gram-negative bacteria: a narrative review","volume":"31","author":"Sangiorgio","year":"2025","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"10.1016\/j.jiph.2025.102841_bib32","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s40264-020-00934-3","article-title":"Safety profile of ceftazidime-avibactam: Pooled data from the adult phase II and phase III clinical trial programme","volume":"43","author":"Cheng","year":"2020","journal-title":"Drug Saf"},{"issue":"8","key":"10.1016\/j.jiph.2025.102841_bib33","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.clinthera.2020.06.005","article-title":"Intravenous compatibility of ceftazidime-avibactam and aztreonam using simulated and actual Y-site administration","volume":"42","author":"O'Donnell","year":"2020","journal-title":"Clin Ther"},{"key":"10.1016\/j.jiph.2025.102841_bib34","doi-asserted-by":"crossref","first-page":"e01008","DOI":"10.1128\/AAC.01008-17","article-title":"Ceftazidime-avibactam and aztreonam, an interesting strategy to overcome beta-lactam resistance conferred by metallo-beta-lactamases in Enterobacteriaceae and Pseudomonas aeruginosa","volume":"61","author":"Davido","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiph.2025.102841_bib35","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.diagmicrobio.2017.05.009","article-title":"Synergistic activity of ceftazidime-avibactam and aztreonam against serine and metallo-beta-lactamase-producing Gram-negative pathogens","volume":"88","author":"Wenzler","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.jiph.2025.102841_bib36","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlad032","article-title":"Aztreonam\/avibactam activity against a large collection of carbapenem-resistant Enterobacterales (CRE) collected in hospitals from Europe, Asia and Latin America (2019-21)","volume":"5","author":"Sader","year":"2023","journal-title":"JAC Antimicrob Resist"},{"issue":"4","key":"10.1016\/j.jiph.2025.102841_bib37","doi-asserted-by":"crossref","DOI":"10.1093\/pcmedi\/pbac029","article-title":"Aztreonam-avibactam: an option against carbapenem-resistant Enterobacterales with emerging resistance","volume":"5","author":"Wu","year":"2022","journal-title":"Precis Clin Med"},{"issue":"5","key":"10.1016\/j.jiph.2025.102841_bib38","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jceh.2022.04.016","article-title":"Ceftazidime-Avibactam for the treatment of carbapenem-resistant Klebsiella pneumoniae infections in patients with liver cirrhosis","volume":"12","author":"Feldman","year":"2022","journal-title":"J Clin Exp Hepatol"},{"issue":"2","key":"10.1016\/j.jiph.2025.102841_bib39","first-page":"183","article-title":"Risk factors for clinical treatment failure and death in patients with ceftazidime-avibactam-resistant Gram-negative bacteria: A single-centre retrospective analysis","volume":"2","author":"Liu","year":"2024","journal-title":"Intell Pharm"},{"key":"10.1016\/j.jiph.2025.102841_bib40","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.2147\/IDR.S435882","article-title":"Clinical efficacy and safety evaluation of deftazidime-avibactam in the treatment of Klebsiella pneumoniae infection: a retrospective analysis from a hospital in China","volume":"16","author":"Xu","year":"2023","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jiph.2025.102841_bib41","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1086\/374245","article-title":"The value of an infectious diseases specialist","volume":"36","author":"Petrak","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2025.102841_bib42","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ijantimicag.2007.12.012","article-title":"Improving the appropriateness of antibiotic prescription in hospitals: A pilot study assessing the effectiveness of an infectious diseases specialist's consultation programme","volume":"31","author":"Della Loggia","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiph.2025.102841_bib43","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s12879-023-08329-2","article-title":"Effect of appropriate empirical antimicrobial therapy on mortality of patients with Gram-negative bloodstream infections: a retrospective cohort study","volume":"23","author":"Xu","year":"2023","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.jiph.2025.102841_bib44","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/jac\/dkaa478","article-title":"Impact of antibiotic timing on mortality from Gram-negative bacteraemia in an English district general hospital: the importance of getting it right every time","volume":"76","author":"Baltas","year":"2021","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.jiph.2025.102841_bib45","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.49353","article-title":"Association of appropriate empirical antimicrobial therapy with in-hospital mortality in patients with bloodstream infections in the US","volume":"6","author":"Ohnuma","year":"2023","journal-title":"JAMA Netw Open"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187603412500190X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187603412500190X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T23:53:12Z","timestamp":1762559592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187603412500190X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S187603412500190X"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2025.102841","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of clinical effectiveness and safety of ceftazidime-avibactam in \u2010treating multi-drug-resistant infections \u2013 A retrospective analysis at a tertiary care hospital in Saudi Arabia","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2025.102841","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}],"article-number":"102841"}}